Excerpts

As shown in Figure 3 A, the 20 M-HP group crossed the platform the most times, 6.39 ± 0.46, which was a significant increase of 47.15% compared with the 20 M-C group of 4.32 ± 0.56 ( p < 0.05); the 16 M-HP group crossed the platform the most times, 5.31 ± 0.78, which was a highly significant increase compared with the 16 M-C group of 2.06 ± 0.34 ( p < 0.05), 157.77% ( p < 0.01); and the 9 M-HP group traversed the platform 4.95 ± 0.89 times with a highly significant improvement of 150% ( p < 0.01) over that of 9 M-C of 1.98 ± 0.14.

Lastly, the authors also observed a borderline significant increase in median IBD-Q in the low-FODMAP diet group ( p = 0.05) with no change in the standard diet group [ 50 ].

Although iron did not show a clearly significant association with depressive symptoms ( p = 0.050), a significant inverse correlation of iron intake in the highest quartile versus lowest quartile was observed with an OR (95%) of 0.484 (0.279–0.841). 4.

There was a trend towards an increase in the proportion of patients classified as sarcopenic; however, this did not reach statistical significance (OR = 2.4, 95%CI = [1.0, 6.0]; p = 0.05).

After false discovery rate ( FDR ) correction, pathway enrichment analyses for genes harboring nominally significant ( p < 0.05) probes identified 44 significant pathways ( q < 0.05), and 5 pathways were related to lipid metabolism.

The borderline significance ( p = 0.050) and wide confidence interval (0.00, 1.07) for the overestimation–restriction for weight control association suggest the estimate is unstable and should not be interpreted as reliable evidence of an effect without replication in a larger, more balanced sample.

Maternal iron supplementation in pregnancy was associated with increased offspring weight ( p = 0.005), head circumference ( p = 0.02), BMI ( p = 0.01), and skinfold thicknesses in three of the four sites ( p = 0.03–0.003) (the fourth having a borderline significance of p = 0.05) ( Table 3 ).

While there was an increasing trend in ULK2 expression among the intervention groups, no significant differences in ULK2 expression were observed between the Aging group and the Normal group ( p > 0.05).

The results showed that Hopeaphenol treatment induced a highly significant increase in the thermal stability of total AMPK protein, with a ΔTm of +4.79 °C compared to the DMSO control ( p < 0.05), while the ΔTm for pAMPK was +0.91 °C ( Figure 4 G,H).

Accordingly, the analysis of the glucagon/insulin ratio in all groups tested showed a trend to increase with respect to the corresponding ratio observed at 0 min; this increase was statistically significant after 60 min ( p < 0.05) of 100 mg/Kg D-Pinitol ( Figure 2 A) dose, and after 120 min ( p < 0.05) of 500 mg/Kg dose of D-Pinitol ( Figure 2 B).

There was borderline significance ( p = 0.05, [ 16 ]) for improved capillary blood velocity (CBV), as measured by NFC of the hallux in the treated group 3 months after receiving 2 μg of paricalcitol. 4.2.

At two months, we observed a trend towards downregulation of 45S and Rrn3 expression in CR fed rats, which was marginally significant ( p -value = 0.05) for Rrn3 .

An increasing trend in the body weight gain was observed in mice of both groups ( p < 0.05), with a percentage increase of 50.47% recorded in ApoE −/− mice fed HFD and 40.94% in ApoE −/− fed HFD + APH.

In a 12-month, double-blind, randomised, placebo-controlled trial (VIDOMA trial), we previously found evidence for a greater improvement with omega-3 LCPUFA with or without vitamin D in social interaction in children with ASD compared with placebo but the difference did not reach statistical significance ( P < 0.05) for most comparisons.

There was also a correlation of borderline significance between the leptin/ghrelin ratio and the percentage of energy from fats (r = 0.32, p = 0.05) ( Table 3 ).

There were no significant differences either in the estimated 14-MEDAS scores between the different age ranges (18–24 years, 6.25 ± 1.73; 25–34 years, 6.09 ± 1.97; 35–44 years, 6.16 ± 2.03; 45–54 years, 6.72 ± 2.18; 55–64 years, 6.14 ± 2.24; 65–81 years, 5.89 ± 2.09; p -value = 0.418) although we detected a small and almost significant negative correlation between age and 14-MEDAS ( r = −0.1, p -value = 0.05).

Data were expressed as means ± standard error of the mean (SEM), 0.05 < p < 0.1 indicated a trend toward significance, 0.01 ≤ p < 0.05 was considered significant, and p < 0.01 was considered extremely significant. 3.

Values of ** p < 0.01, *** p < 0.001, or **** p < 0.0001 were considered highly significant, and p > 0.05 (ns) was considered not statistically significant.

Meanwhile, the authors found that Se supplementation improved thyroid function in women with thyroiditis, for which the decreased TSH levels became almost significantly lower than in females with thyroiditis on the placebo ( p = 0.05).

Due to the trend toward significance in TRGs and the higher postprandial GLU in the SF smoothie, there was a higher MLI as an interaction between time and condition ( p = 0.05).

Similarly, a decreasing trend in Adiponectin gene expression was found for the 50μg/mL dosage of FCa, which became significant when FCa 80 μg/mL was tested ( p < 0.05).

Biochemical test results of the metabolic indicators showed that the AST level decreased at 25 μM while showing an increasing trend within the range of 50–100 μM; despite that, the differences among different groups was not significant ( p > 0.05).

It should be noted that this difference did not reach statistical significance based on the Mann-Whitney U test (U = 61; the critical value of U at p < 0.05 is 45).

However, comparison of peak concentrations with baseline showed a borderline significant ( p = 0.05) increase from baseline levels after the Neutr-meal, for which postprandial increases in IL-6 and IL-1β were also observed.

Provisionally significant results of the same direction (i.e., p < 0.05, where NCGS respondents more often reported the condition), but which did not survive this correction, were also reported for thyroid disease and fibromyalgia.